Related Experiment Video
Updated: May 22, 2026
08:56
Kinetic Measurement and Real Time Visualization of Somatic Reprogramming
Published on: July 30, 2016
Assessing iPSC reprogramming methods for their suitability in translational medicine.
1National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Laboratory of Stem Cell Biology, Bethesda, MD, USA. raomah@mail.nih.gov
Journal of Cellular Biochemistry
|May 11, 2012
Summary
Generating induced pluripotent stem cells (iPSCs) from somatic cells offers transformative potential for medicine. Selecting the right reprogramming method is crucial for advancing iPSC technology towards clinical applications and translational medicine.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Molecular biology
Background:
- Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) via transcription factor overexpression.
- iPSCs hold promise for pharmaceutical development and cellular transplantation therapies.
- Effective clinical translation of iPSC technology hinges on appropriate method selection.
Purpose of the Study:
- To review current iPSC reprogramming techniques.
- To critically evaluate these methods based on their translational medicine utility.
- To guide researchers in selecting optimal reprogramming strategies for clinical applications.
Main Methods:
- Comprehensive literature review of existing iPSC reprogramming methodologies.
- Comparative analysis of techniques focusing on efficiency, safety, and scalability.
- Evaluation of reprogramming methods through the lens of translational medicine requirements.
Main Results:
- Detailed overview of various iPSC generation methods, including viral, non-viral, and transient delivery systems.
- Critique of each method's strengths and weaknesses concerning clinical applicability.
- Identification of key factors influencing the suitability of iPSCs for therapeutic use.
Conclusions:
- The choice of reprogramming technique significantly impacts the clinical viability of iPSCs.
- Further optimization of reprogramming methods is needed to enhance safety and efficacy for translational medicine.
- Selecting the appropriate method is paramount for harnessing the full potential of iPSC technology in healthcare.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.